Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Pea · SciRah

Researcher profile · Semantic Scholar

F. Pea

Share profile

F. Pea — researcher profile on SciRah

h-index: 51
Works: 416
Citations: 12K

Most-cited papers

Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis
M. Gatti, P. Cojutti, F. Pea
2024Critical Care77 citations Open access
Semantic Scholar
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use
M. Sartelli, C. Tascini, F. Coccolini, Fabiana Dellai +58 more
2024World Journal of Emergency Surgery57 citations Open access
Semantic Scholar
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams
M. Gatti, F. Pea
2023Expert Review of Anti-Infective Therapy47 citations
Semantic Scholar
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales
Tanaya Bhowmick, Rafael Cantón, F. Pea, J. Quevedo +3 more
2025Future Microbiology45 citations Open access
Semantic Scholar
Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis.
M. Gatti, Federica Cosentino, M. Giannella, P. Viale +1 more
2023International Journal of Antimicrobial Agents40 citations Open access
Semantic Scholar
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation.
P. Cojutti, M. Gatti, F. Bonifazi, F. Caramelli +18 more
2023International Journal of Antimicrobial Agents24 citations Open access
Semantic Scholar
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?
M. Gatti, M. Rinaldi, Cecilia Bonazzetti, P. Gaibani +3 more
2023Antimicrobial Agents and Chemotherapy23 citations Open access
Semantic Scholar
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
M. Gatti, M. Rinaldi, P. Gaibani, A. Siniscalchi +4 more
2023Journal of critical care22 citations Open access
Semantic Scholar
A descriptive case series of the relationship between maintenance over time of conservative PK/PD efficacy thresholds of dalbavancin and clinical outcome in long-term treatment of staphylococcal osteoarticular infections.
M. Gatti, P. Viale, P. Cojutti, E. Zamparini +4 more
2023International Journal of Antimicrobial Agents22 citations Open access
Semantic Scholar
Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: a systematic review and meta-analysis.
M. Gatti, P. Cojutti, F. Pea
2024Journal of Global Antimicrobial Resistance17 citations Open access
Semantic Scholar
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales
P. Cojutti, M. Pai, T. Tonetti, A. Siniscalchi +2 more
2024Antimicrobial Agents and Chemotherapy16 citations Open access
Semantic Scholar
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study
M. Rinaldi, M. Gatti, T. Tonetti, Domenico Nocera +8 more
2024Annals of Intensive Care15 citations Open access
Semantic Scholar
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections.
P. Cojutti, M. Gatti, N. Punt, Jiři Douša +4 more
2023International Journal of Antimicrobial Agents15 citations Open access
Semantic Scholar
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on
M. Gatti, M. Rinaldi, P. Cojutti, Cecilia Bonazzetti +7 more
2025Antimicrobial Agents and Chemotherapy14 citations Open access
Semantic Scholar
An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients.
P. Cojutti, Manjunath P. Pai, M. Gatti, M. Rinaldi +3 more
2024Journal of Antimicrobial Chemotherapy14 citations
Semantic Scholar
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients.
P. Gaibani, Federica Bovo, L. Bussini, M. Bartoletti +4 more
2023Clinical Microbiology and Infection14 citations Open access
Semantic Scholar
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections
P. Cojutti, M. Gatti, S. Tedeschi, E. Zamparini +16 more
2025Antimicrobial Agents and Chemotherapy13 citations Open access
Semantic Scholar
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem Mass Spectrometry for Therapeutic Drug Monitoring
R. Barone, M. Conti, Beatrice Giorgi, M. Gatti +3 more
2023Antibiotics12 citations Open access
Semantic Scholar
Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis
M. Gatti, P. Cojutti, M. Rinaldi, S. Ambretti +3 more
2025Therapeutic Drug Monitoring11 citations Open access
Semantic Scholar
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
Carla Troisi, P. Cojutti, M. Rinaldi, C. Laici +3 more
2023Pharmaceutics11 citations Open access
Semantic Scholar
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections
P. Cojutti, Simone Giuliano, R. Pascale, Jacopo Angelini +3 more
2023Microorganisms9 citations Open access
Semantic Scholar
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
P. M. Berrino, M. Gatti, M. Rinaldi, E. Brunocilla +2 more
2023Antibiotics9 citations Open access
Semantic Scholar
Development and Validation of a Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples
Matteo Conti, Beatrice Giorgi, M. Gatti, P. Viale +1 more
2024Therapeutic Drug Monitoring8 citations
Semantic Scholar
Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data
Tommaso Giacometti, E. Rocchi, P. Cojutti, Federico Magnani +3 more
2025Entropy7 citations Open access
Semantic Scholar
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper
L. Bussini, M. Bartoletti, M. Bassetti, A. Cortegiani +13 more
2025Journal of Anesthesia Analgesia and Critical Care7 citations Open access
Semantic Scholar
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow
M. Gatti, F. Pea
2025Expert Review of Anti-Infective Therapy7 citations
Semantic Scholar
Which Are the Best Regimens of Broad-Spectrum Beta-Lactam Antibiotics in Burn Patients? A Systematic Review of Evidence from Pharmacology Studies
G. Tebano, G. la Martire, Luigi Raumer, M. Cricca +3 more
2023Antibiotics7 citations Open access
Semantic Scholar
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative Infections
M. Gatti, C. Campoli, M. E. Latrofa, S. Ramirez +5 more
2023The Pediatric Infectious Disease Journal7 citations Open access
Semantic Scholar
Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients
P. Cojutti, A. Heffernan, T. Tängdén, P. Della Siega +3 more
2023Antimicrobial Agents and Chemotherapy7 citations Open access
Semantic Scholar
Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observati
M. Gatti, M. Rinaldi, C. Laici, Cecilia Bonazzetti +7 more
2025Journal of Infectious Diseases6 citations Open access
Semantic Scholar
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis
Stella Babich, P. Cojutti, M. Gatti, F. Pea +2 more
2025JAC-Antimicrobial Resistance6 citations Open access
Semantic Scholar
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in a Klebsiella pneumoniae from a critical ill patient during cefiderocol and ceftazidime/avibactam based treatments.
Stefano Amadesi, M. Gatti, M. Rinaldi, F. Pea +2 more
2024International Journal of Antimicrobial Agents6 citations
Semantic Scholar
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections
P. Cojutti, S. Tedeschi, E. Zamparini, P. Viale +1 more
2024Clinical Pharmacokinetics6 citations Open access
Semantic Scholar
Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?
M. Gatti, F. Pea
2025Infectious Disease Reports5 citations Open access
Semantic Scholar
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
Manjunath P. Pai, P. Cojutti, M. Gatti, M. Rinaldi +4 more
2025Antimicrobial Agents and Chemotherapy5 citations Open access
Semantic Scholar
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
M. Gatti, M. Rinaldi, Cecilia Bonazzetti, A. Siniscalchi +5 more
2025Journal of Antimicrobial Chemotherapy5 citations Open access
Semantic Scholar
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria
Cecilia Bonazzetti, M. Rinaldi, Federica Cosentino, M. Gatti +9 more
2024Transplant Infectious Disease5 citations
Semantic Scholar
Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review
M. Gatti, F. Pea
2024Frontiers in Antibiotics5 citations Open access
Semantic Scholar
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis
M. Gatti, Riccardo De Paola, Beatrice Giorgi, F. Pea
2026Clinical Infectious Diseases4 citations Open access
Semantic Scholar
Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae
M. Gatti, M. Rinaldi, C. Laici, A. Siniscalchi +4 more
2025Journal of Antimicrobial Chemotherapy4 citations Open access
Semantic Scholar
Pediatric stewardship in Italy: a necessity, not an option - a National Multi-Society Expert Consensus on Antimicrobial and Diagnostic Stewardship (SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN)
D. Donà, E. Barbieri, G. Brigadoi, M. Barchitta +49 more
2025Italian Journal of Pediatrics4 citations Open access
Semantic Scholar
Role of a Therapeutic Drug Monitoring-Guided Strategy of Isavuconazole for Optimizing Efficacy/Safety Outcomes in Onco-Hematological Pediatric Patients: A Systematic Review
M. Gatti, P. Cojutti, F. Pea
2025Chemotherapy4 citations
Semantic Scholar
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
M. Gatti, M. Rinaldi, T. Tonetti, A. Siniscalchi +2 more
2024Antibiotics4 citations Open access
Semantic Scholar
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study
M. Gatti, Cecilia Bonazzetti, R. Pascale, M. Giannella +2 more
2024Microorganisms4 citations Open access
Semantic Scholar
When and How to Use Subcutaneous Antibiotics
Stefano Di Bella, N. Geremia, F. Pea, M. Zeitlinger +7 more
2026Clinical Infectious Diseases3 citations Open access
Semantic Scholar
Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma
Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola, M. Gatti +1 more
2026Pharmaceutics3 citations Open access
Semantic Scholar
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?
P. Cojutti, S. Tedeschi, E. Zamparini, G. Fornaro +4 more
2025Antibiotics3 citations Open access
Semantic Scholar
Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an update
M. Gatti, F. Pea
2025Expert Review of Anti-Infective Therapy3 citations
Semantic Scholar
Targeting Pseudomonas aeruginosa resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
P. Cojutti, Manjunath P. Pai, M. Gatti, M. Rinaldi +4 more
2025Antimicrobial Agents and Chemotherapy3 citations Open access
Semantic Scholar
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients
M. Gatti, M. Rinaldi, C. Laici, S. Ambretti +3 more
2024Journal of Antimicrobial Chemotherapy3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Gatti×38
Invite
M. Gatti — researcher profile on SciRah
P. Viale×22
Invite
P. Viale — researcher profile on SciRah
M. Giannella×14
Invite
M. Giannella — researcher profile on SciRah
P. Cojutti×13
Invite
P. Cojutti — researcher profile on SciRah

×12

Invite

M. Rinaldi — researcher profile on SciRah

Invite

P. Viale — researcher profile on SciRah

A. Siniscalchi×10

Invite

A. Siniscalchi — researcher profile on SciRah

Invite

T. Tonetti — researcher profile on SciRah

Invite

S. Ambretti — researcher profile on SciRah

Invite

P. Cojutti — researcher profile on SciRah

Cecilia Bonazzetti×6

Invite

Cecilia Bonazzetti — researcher profile on SciRah

Invite

C. Tascini — researcher profile on SciRah